Obstetrician with Saolta University Healthcare Group urges those taking prenatal testing to “err on the side of caution” as it is not 100% accurate.
Non-Invasive Prenatal Testing is a new screening test that can identify if your baby is likely to have a chromosomal condition. Some of the syndromes are fatal and the baby will die either before birth or shortly afterwards. This can provide valuable information about your baby’s health and helps expectant mothers to understand the risks and benefits.
However, what happens when the diagnosis is wrong? For one mother, she was told her baby was developing a fatal foetal abnormality called ‘Hydrops’, and had a 3% survival rate. Despite the option to terminate the foetus, she decided to continue with her pregnancy. Today, she has a “perfect” Down’s Syndrome girl with no health problems or risk factors.
Her Obsterician, Michelle McGreal, tells her story.
